A carregar...
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative treatment for myelodysplastic syndromes (MDS), but patients who relapse after transplant have poor outcomes. In order to understand the contribution of tumor clonal evolution to disease progression,we applied exome and...
Na minha lista:
| Publicado no: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5922277/ https://ncbi.nlm.nih.gov/pubmed/29515031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.98962 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|